Literature DB >> 1869450

A diurnal variation of vasoactive intestinal peptide (VIP) mRNA under a daily light-dark cycle in the rat suprachiasmatic nucleus.

S Okamoto1, H Okamura, M Miyake, Y Takahashi, S Takagi, Y Akagi, K Fukui, H Okamoto, Y Ibata.   

Abstract

We detected a diurnal change of vasoactive intestinal peptide (VIP) messenger RNA (mRNA) in the rat suprachiasmatic nucleus (SCN) using the in situ hybridization technique combined with computed image analysis. The amount of VIP mRNA was greatest at 02.00 h, the next largest level was seen at 20.00 h during the dark phase and smallest at 14.00 h during the light phase. We also confirmed that the onset of the fluctuation of mRNA occurred 2-6 h prior to the diurnal variation of the content of VIP-like immunoreactivity by semiquantitative immunocytochemistry. These findings suggest that light stimulus from the retina is a primarily influence on the transcription of VIP mRNA and induces a diurnal variation of VIP synthesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1869450     DOI: 10.1007/bf00315750

Source DB:  PubMed          Journal:  Histochemistry        ISSN: 0301-5564


  17 in total

1.  Identification of the vasopressin-neurophysin producing neurons of the rat suprachiasmatic nuclei.

Authors:  F Vandesande; K Dierickx; J DeMey
Journal:  Cell Tissue Res       Date:  1975       Impact factor: 5.249

2.  Demonstration of GABAergic cell bodies in the suprachiasmatic nucleus: in situ hybridization of glutamic acid decarboxylase (GAD) mRNA and immunocytochemistry of GAD and GABA.

Authors:  H Okamura; A Bérod; J F Julien; M Geffard; K Kitahama; J Mallet; P Bobillier
Journal:  Neurosci Lett       Date:  1989-07-31       Impact factor: 3.046

3.  Lactation elevates vasoactive intestinal peptide messenger ribonucleic acid in rat suprachiasmatic nucleus.

Authors:  I Gozes; R Avidor; A Biegon; F Baldino
Journal:  Endocrinology       Date:  1989-01       Impact factor: 4.736

4.  Persistence of circadian rhythmicity in a mammalian hypothalamic "island" containing the suprachiasmatic nucleus.

Authors:  S T Inouye; H Kawamura
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

5.  A retinohypothalamic projection in the rat.

Authors:  R Y Moore; N J Lenn
Journal:  J Comp Neurol       Date:  1972-09       Impact factor: 3.215

6.  Transplantation of the neonatal suprachiasmatic nuclei into rats with complete bilateral suprachiasmatic lesions.

Authors:  Y Sawaki; I Nihonmatsu; H Kawamura
Journal:  Neurosci Res       Date:  1984-02       Impact factor: 3.304

7.  Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions.

Authors:  F K Stephan; I Zucker
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

8.  Localization of vasoactive intestinal peptide and peptide histidine isoleucine immunoreactivity and mRNA within the rat suprachiasmatic nucleus.

Authors:  E G Stopa; N Minamitani; J A Jonassen; J C King; H Wolfe; H Mobtaker; H E Albers
Journal:  Brain Res       Date:  1988-12       Impact factor: 3.252

9.  Vasoactive intestinal peptide immunoreactive neurons in the rat suprachiasmatic nucleus demonstrate diurnal variation.

Authors:  Y Takahashi; H Okamura; N Yanaihara; S Hamada; S Fujita; Y Ibata
Journal:  Brain Res       Date:  1989-09-18       Impact factor: 3.252

10.  Suprachiasmatic nucleus vasopressin messenger RNA: circadian variation in normal and Brattleboro rats.

Authors:  G R Uhl; S M Reppert
Journal:  Science       Date:  1986-04-18       Impact factor: 47.728

View more
  14 in total

1.  Development of vasoactive intestinal peptide mRNA rhythm in the rat suprachiasmatic nucleus.

Authors:  Y Ban; Y Shigeyoshi; H Okamura
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

2.  Oxytocin action at the lactotroph is required for prolactin surges in cervically stimulated ovariectomized rats.

Authors:  De'Nise T McKee; Maristela O Poletini; Richard Bertram; Marc E Freeman
Journal:  Endocrinology       Date:  2007-07-05       Impact factor: 4.736

Review 3.  VIP as a cell-growth and differentiation neuromodulator role in neurodevelopment.

Authors:  J M Muller; V Lelievre; L Becq-Giraudon; A C Meunier
Journal:  Mol Neurobiol       Date:  1995 Apr-Jun       Impact factor: 5.590

Review 4.  Neuropeptides as growth and differentiation factors in general and VIP in particular.

Authors:  I Gozes; D E Brenneman
Journal:  J Mol Neurosci       Date:  1993       Impact factor: 3.444

5.  Distinct Firing Properties of Vasoactive Intestinal Peptide-Expressing Neurons in the Suprachiasmatic Nucleus.

Authors:  Tracey O Hermanstyne; Carrie L Simms; Yarimar Carrasquillo; Erik D Herzog; Jeanne M Nerbonne
Journal:  J Biol Rhythms       Date:  2015-12-27       Impact factor: 3.182

6.  Regulation of vasoactive intestinal polypeptide release in the suprachiasmatic nucleus circadian clock.

Authors:  Jessica M Francl; Gagandeep Kaur; John David Glass
Journal:  Neuroreport       Date:  2010-11-17       Impact factor: 1.837

7.  Changes in vasoactive intestinal peptide and arginine vasopressin expression in the suprachiasmatic nucleus of the rat brain following footshock stress.

Authors:  Robert J Handa; R Thomas Zoeller; Robert F McGivern
Journal:  Neurosci Lett       Date:  2007-08-25       Impact factor: 3.046

8.  Vasoactive intestinal peptide/peptide histidine isoleucine mRNA in the eye and suprachiasmatic nucleus of normal and monocularly enucleated rats.

Authors:  P Denis; M Dussaillant; J P Nordmann; A Bérod; H Saraux; W Rostène
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-09       Impact factor: 3.117

9.  The effects of acute phencyclidine treatment on neuropeptide Y (NPY) neuronal system in the rat arcuate nucleus studied by immunocytochemistry and in situ hybridization.

Authors:  K Fukui; Y Kawashima; H Iizumi; H Utsumi; T Nakajima
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

10.  A mathematical model for the mating-induced prolactin rhythm of female rats.

Authors:  Richard Bertram; Marcel Egli; Natalia Toporikova; Marc E Freeman
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-03       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.